Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
17,750,268
-
Shares change
-
+2,180,358
-
Total reported value, excl. options
-
$5,002,997,878
-
Value change
-
+$659,415,345
-
Put/Call ratio
-
101%
-
Number of buys
-
126
-
Number of sells
-
75
-
Price
-
$282.02
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q1 2015
As of 31 Mar 2015 INTERCEPT PHARMACEUTICALS IN - COM (ICPT) had 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,750,268 shares of stock of the company.
Largest 10 holders included FMR LLC, Carmignac Gestion, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Ameriprise Financial Inc, Capital World Investors, FIRST TRUST ADVISORS LP, FRED ALGER MANAGEMENT INC, JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 199 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.